Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Chuah, Charles
[Clear All Filters]
2015
Sun WTian
,
Xiang W
,
Ng BLing
,
Asari K
,
Bunte RM
,
Casey PJ
,
Wang M
,
Chuah C
.
Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukaemia.
Exp Hematol. 2015.
PubMed
Google Scholar
2018
Ng KPan
,
Manjeri A
,
Lee LMing
,
Chan ZEn
,
Tan CYee
,
Tan QDarren
,
Majeed A'Q
,
Lee KLeong
,
Chuah C
,
Suda T
, et al.
The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
PLoS One. 2018;13(10):e0205254.
PubMed
Google Scholar
2019
Yi HLam
,
Than H
,
Sng C
,
Cheong MAnne
,
Chuah C
,
Xiang W
.
Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia.
Transl Oncol. 2019;12(9):1221-1228.
PubMed
Google Scholar
2022
Xiang W
,
Lam YHui
,
Periyasamy G
,
Chuah C
.
Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.
Int J Mol Sci. 2022;23(5).
PubMed
Google Scholar